￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is talazoparib effective?

2026-02-01 22:25:32

Check Details
The launch status of talazoparib in China in 2024 and the latest information on medical insurance

2026-02-01 22:25:32

Check Details
Detailed explanation of the price and purchase method of generic talazoparib

2026-02-01 22:25:32

Check Details
Who is talazoparib suitable for?

2026-02-01 22:25:32

Check Details
Detailed instructions for use of the Lao version of talazoparib

2026-02-01 22:25:32

Check Details
What is the risk of relapse after stopping ibrutinib?

2026-02-01 22:25:32

Check Details
Ibrutinib Medication Guide: Detailed explanation of correct usage and dosage

2026-02-01 22:25:32

Check Details
Detailed explanation of ibrutinib 2024 medical insurance reimbursement policy

2026-02-01 22:25:32

Check Details
Who is Ibrutinib capsule suitable for treating?

2026-02-01 22:25:32

Check Details
When should ibrutinib capsules be discontinued?

2026-02-01 22:25:32

Check Details
Aceminid Dosing Guide + Maximum Dose, Adjustments

2026-02-01 22:25:32

Check Details
Aceminib shows sustained response rate in patients with chronic myelogenous leukemia at 48 weeks of follow-up

2026-02-01 22:25:32

Check Details
Category
相关知识